Parkinson disease (PD)—characterized by cardinal features of bradykinesia, rest tremor, and rigidity
1 — is the second most common neurodegenerative disease. Incidence and prevalence estimates vary depending on source, age, and case definitions.
2-4 In Denmark, incidence has been estimated at 23 per 100 000 person-years,
5 while a systematic literature review of European studies reported an incidence range from 5 to 346 per 100 000.
6 In the US, a study that estimated incidence over 30 years reported a rate of 17 per 100 000 person-years for men and women combined.
7 The pathological cascade preceding neurological symptoms is hypothesized to span 10 to 20 years or longer.
8 While most PD cases are idiopathic, others are linked to known genetic variants
3 or to suspected lifestyle factors and environmental exposures.
2,3